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ABSTRACT: Herein, we report a straightforward method for the scalable preparation of Pd nanoparticles (Pd-NPs) with
reduced inherent cytotoxicity and high photothermal conversion capacity. These Pd-NPs are rapidly taken up by cells and able to
kill labeled cancer cells upon short exposure to near-infrared (NIR) light. Following cell treatment with Pd-NPs, ablated areas
were patterned with high precision by laser scanning microscopy, allowing one to perform cell migration assays with
unprecedented accuracy. Using coherent Raman microscopy, cells containing Pd-NPs were simultaneously ablated and imaged.
This novel methodology was combined with intravital imaging to mediate microablation of cancerous tissue in tumor xenografts
in mice.
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■ INTRODUCTION
Photothermal ablation (PTA) is an optochemical method that
employs benign electromagnetic radiations, preferably in the
near-infrared region, to irradiate and kill cells (e.g., cancer cells)
that have been pretargeted with photosensitive plasmonic
materials.1,2 Such materials, which typically consist of nontoxic
cell-permeant nanostructures, release the absorbed energy as
heat causing local hyperthermia and selectively disrupting the
integrity of labeled cells. Plasmonic nanomaterials displaying
photothermal activity under deep-penetrating NIR irradiation
include various nanoarchitectures of noble metals (gold, silver,
etc.), semiconductor quantum dots, and carbon-based nano-
materials (carbon nanotubes, graphene, organic nanopar-
ticles).1−4 While PTA is generally considered an extension of
photodynamic therapy (PDT),5 this “tag-&-kill” approach does
not require oxygen to elicit its therapeutic action; a critical
advantage for example for the prospective treatment of late
stage hypoxic tumors. PTA together with PDT5,6 and other
emerging strategies, such as photopharmacology7,8 and
bioorthogonally activated prodrugs,9−13 form a distinctive
group of therapeutic approaches with the common feature of
being “switched on” through bioindependent triggering stimuli,
e.g., harmless electromagnetic waves, bioorthogonal partners,
biocompatible catalysts, etc. The goal of these strategies is to
minimize systemic adverse effects of cancer treatment by taking
control of where and when the therapeutic intervention takes
place.
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Due to their remarkable chemical and optical properties, Pd
nanostructures have recently emerged as a new player in the
field of nanomedicine.14,15 Polymer-entrapped Pd-NPs exhibit
an exceptional capacity to elicit local bioorthogonal activation
of different chemotherapeutic agents,11,16−18 while Pd nano-
sheets and porous Pd-NPs facilitate the induction of local
hyperthermia upon exposure to NIR irradiation.19,20 Despite
these encouraging studies, safety concerns associated with the
potential toxicity and immunogenicity of Pd-NP in vivo21−23
are deterring the advance of such technologies to the clinic.
This has motivated efforts to develop Pd-based nanomaterials
with high biocompatibility. Tilley and co-workers recently
reported a method to deposit gold nanocrystals on highly
branched Pd seeds as a way to increase the safety of the device
and produce a NIR-absorbing composite nanostructure for
photothermal therapy.24 Other groups have exploited the
natural reductant properties of plants and microbial extracts for
the preparation of Pd-NPs (so-called biogenic synthesis),25
which has resulted in the discovery of Pd-NPs with preferential
ability to kill malignant cells over normal cells.26,27
Herein, we report a straightforward, scalable method to
prepare Pd-NPs with high biocompatibility and plasmonic
photothermal efficacy. These nanodevices enter cancer cells
with high efficiency, remain in the cytoplasm without causing
direct cell damage, and induce thermal ablation under harmless
NIR laser irradiation. Using coherent Raman microscopy,
ablation of Pd-labeled cells was ignited and simultaneously
imaged in real-time both in vitro and in vivo. Cell labeling with
Pd-NPs followed by laser microscopy-controlled irradiation
enabled highly accurate patterning of denuded areas within a
cell monolayer allowing the study of cancer cell migration and
invasion with a level of accuracy that improves upon standard
scratch wound healing assays.
■ RESULTS AND DISCUSSION
Rationale, Synthetic Procedure, and Characterization.
Recent studies26,27 have reported the use of natural extracts as
biogenic reductants to produce Pd-NPs with preferential
cytotoxic activity toward cancerous cells. Such selective
properties might be, at least in part, a consequence of the
combined action of bioactive substances present in the extracts
being adsorbed at the NP surface.28 Although this approach
may be beneficial for the direct therapeutic use of such
nanodevices, our goal was to develop an entirely biocompatible
class of Pd-NPs to explore their bioorthogonal potential either
to catalyze abiotic chemical processes11,15 or to generate heat
under harmless light irradiation.14
We envisioned that antioxidants and metal chelators found in
human cells could be exploited to drive the reduction of soluble
Pd(II) species into safe, well-characterized Pd-NPs. First, we
tested four water-soluble natural antioxidants: ascorbate
(vitamin C), uric acid, glutathione, and melatonin. Reactions
were performed in water at 37 °C to mimic physiological
conditions. As expected,29−31 the addition of sodium ascorbate
to a solution of palladium nitrate dihydrate (Pd(NO3)2·2H2O)
led to the rapid generation of Pd-NPs, which was visually
observed by a color change from brown to black. In contrast,
glutathione and uric acid did not induce any color change to
the mixture, indicating that Pd(II) is not reduced under such
conditions. Interestingly, melatonin treatment at 37 °C for 6 h
successfully reduced the Pd(II) salt into Pd0. This is
noteworthy as there are no references of the use of melatonin
for the reduction of Pd(II) species. Unfortunately, instead of
Pd-NPs, polydispersed microparticles were generated, making
this method suboptimal for the purpose of this work. This
novel green synthesis method of Pd powders may however find
application in the microelectronics industry.32
Li and co-workers31 have shown that sodium ascorbate can
play a dual reductant/particle stabilizer role and generate Pd-
NPs from different Pd(II) complexes in neat conditions by
direct grinding in a mortar. Encouraged by the simplicity and
scalability of this method, we adapted Li’s protocol to prepare
Pd-NP using Pd(NO3)2·2H2O (1), sodium ascorbate (2), and
histidine (3) (Figures 1a and S1). The natural amino acid 3 was
used because of its high affinity to coordinate Pd atoms, its
basic properties (the imidazole ring is partly protonated at
physiological pH), and its antioxidant scavenging properties,
especially against singlet oxygen33 (one of the expected
cytotoxic mechanisms attributed to Pd species34). We
Figure 1. Green synthesis and characterization of Pd-NP. (a) Pd-NPs were prepared by neat grinding in a mortar using the recipe described in the
table followed by oven drying at 80 °C. Pd content (w/w) was determined by inductively coupled plasma optical emission spectrometry (ICP-OES).
(b) Size distribution histograms (≥150 particles measured per sample; SD = standard deviation) and (c) representative transmission electron
microscopy (TEM) images of Pd-NP A (top), B (middle), and C (bottom). Histograms were generated by analysis of the TEM images.
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hypothesized that the adsorption of histidine molecules at the
surface of the NPs would generate a positively charged layer at
the periphery of the NPs to enhance intracellular delivery and
partially neutralize the formation of Pd-mediated cell-damaging
reactive oxygen species (ROS). This strategy would also help to
decouple the photothermal from the photodynamic effect.
Three types of Pd-NP were prepared following the sequence
described in Figure 1a (see full protocol in the Figure S1). On
the basis of the amount of 3 used in the syntheses, Pd content
(measured by ICP-OES) ranged from 12.1 wt % (Pd-NP A) to
4.4 wt % (Pd-NP C). TEM analysis showed that smaller
nanoparticles were generated in the absence of histidine (Pd-
NP A, mean size = 3.1 nm) in comparison to those containing
the amino acid (Pd-NP B and C, mean sizes = 6.5 nm; see high
resolution TEM in the Figure S2). X-ray powder diffraction
(XRD) patterns (see Figure S3) showed the expected
diffraction peaks attributed to Pd(0) and 2 in the three
preparations. Signals confirming the presence of 3 in Pd-NP B
and C were identified by XRD and Fourier-transform IR
spectrometry (Figure S4).
Study of Pd-NP Biocompatibility and Intracellular
Translocation. Chemicals containing Pd species are generally
considered toxic.35,36 Unbound Pd(II) complexes are reported
to be poisonous,36 while different types of Pd nanostructures
have been shown to display cytotoxic activity against bacteria
and cancer cells.26,27,37 However, there is sufficient evidence to
state that some Pd-containing materials are safer than
others.38,39 According to the European Medicines Evaluation
Agency (EMEA), depending on the Pd reagent and the route of
administration, median lethal dose values (LD50) can drastically
oscillate from 3 to 4900 mg/kg body weight,39 evidencing that
safety risks should not be generalized but evaluated in a case-
by-case basis.
To determine whether the novel Pd-NPs were optimal for
bioorthogonal applications, cell viability studies were carried
out in human lung adenocarcinoma A549 cells. Cells were
seeded in a 96-well plate and incubated for 48 h before
treatment. Cells were then treated with increasing quantities of
Pd-NP A, B, and C for 5 d, and cell viability was determined by
the PrestoBlue assay. Pd(NO3)2·2H2O, 1, was tested alongside
as a control, and each experiment was performed in triplicates.
Treatment with the Pd(II) salt 1 at 0.2 mg/mL led to complete
cell death, whereas no signs of toxicity were observed at that
concentration with the Pd-NPs. Notably, histidine-containing
Pd-NP B and C exhibited a superior safety profile (Figure 2a).
While compound 1 and Pd-NP A showed a drastic increase in
cytotoxicity across a very narrow concentration range, the dose
response curves of Pd-NP B and C displayed an attenuated
slope. This reduced antiproliferative effect could be attributed
to the ROS scavenging properties of histidine.33
Next, the capacity of the Pd-NPs to label lung cancer A549
cells was studied by measuring intracellular Pd content after 24
h of treatment. To ensure only internalized Pd-NPs were
measured, cells were treated with 0.2 mg/mL of Pd-NP A, B,
and C and then washed twice with PBS, trypsinized, and
centrifuged. The supernatant was disposed, and the pellets were
resuspended in the digestion solution and analyzed by ICP-
OES. As shown in Figure 2b, Pd content in cells treated with
Pd-NP C was negligible, which may explain their very low toxic
effect on this cell line. Remarkably, the capacity of Pd-NP B to
label A549 cells was over 3-fold higher than that of Pd-NP A.
This is noteworthy because Pd-NP B contains a lower
proportion of Pd in its structure than Pd-NP A and,
importantly, Pd-NP B is also more biocompatible. To verify
that Pd-NP B was able to enter the cell cytoplasm, rather than
being adsorbed on the cell membrane, cells were treated with
Pd-NP B following the same protocol described before. After
labeling, detachment, and centrifugation, cells were resus-
pended in fresh media and replated over a sterile coverslip.
Following 24 h of incubation, cells were fixed with
paraformaldehyde and processed for Cryo-TEM analysis.
TEM images confirmed the presence of Pd-NP B inside the
cells, which appeared as clusters of various sizes across the cell
cytoplasm (Figure 2c).
Analysis of the colloidal stability of each of the NPs in the
presence of serum (see Figure S6) revealed that Pd-NP B
produced particles of relatively stable size (approximately 200
nm in average diameter). On the contrary, the colloidal
suspension generated by Pd-NP C under such conditions
varied significantly over time, which may account for the low
cell entry observed with Pd-NP C and, consequently, for its low
cytotoxic effect.
Chemical and Optical Properties of Pd-NP A, B, and C:
Absorbance and Photothermal Activity. After finding that
Pd-NP B was optimal to label cancer cells and stay harmlessly
in the cell cytoplasm, a series of in vitro functional studies were
carried out to assess the capabilities of these nanodevices to
perform bioorthogonal tasks.
On the basis of our interest in bioorthogonal organometallic
(BOOM) chemistry,40,41 the catalytic properties of Pd-NP B in
biocompatible environments were evaluated using a selection of
Pd-labile pro-dyes in PBS with and without 10% fetal bovine
serum (FBS). While the nanodevices showed a high capacity to
activate probes 4b and 4c in PBS, their catalytic activity in PBS
supplemented with FBS was significantly lower (see Figure S7),
Figure 2. Cell viability and NP penetrability studies in A549 cells. (a)
Dose response curves after treatment with 1, Pd-NP A, B, and C. Cell
viability was measured at day 5 using the PrestoBlue reagent. Error
bars: ±SD from n = 3. (b) Quantification of Pd content inside cells as
a percentage of the concentration used for the treatment. Analyses
were performed by ICP-OES. (c) Representative Cryo-TEM image of
a Pd-NP B-treated cell cross-section showing the membrane and the
cytoplasm of a lung cancer A549 cell. NP clusters are indicated with
white arrows. Scale bar = 500 nm. ***P ≤ 0.001.
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indicating that these nanoparticles are deactivated by serum
components and therefore not suitable to perform intracellular
BOOM catalysis.
A remarkable feature of Pd nanostructures that has attracted
the attention of the nanomedical field in recent years is their
capacity to absorb light in the NIR range and transform it into
heat, which has been used preclinically to mediate PTA of
prelabeled cancer cells both in vitro and in vivo.19,20 0.2 mg/mL
suspensions of Pd-NP A, B, and C in PBS were first analyzed
with a spectrophotometer at 400−800 nm to assess the
absorbance properties of the NPs across the UV−vis spectrum,
with particular interest in the NIR. Notably, Pd-NP B and C
(both of which contain histidine) displayed enhanced light
absorbing properties, with the preparation of Pd-NP B
exhibiting the highest absorbance (see Figure S8). This is an
interesting observation as the total quantity of Pd metal in the
preparations of Pd-NP B and C is lower than in that of Pd-NP
A. As histidine does not absorb light on its own, this indicates
that NP-bound histidine molecules are involved in the
improved capacity of the materials to absorb light.
The photothermal properties of the suspensions were then
analyzed under laser and light-emitting diode (LED)
irradiation. Laser photothermal measurements were performed
using a NIR laser system consisting of an 808 nm laser diode
and with a green 532 nm laser diode (Changchun New
Industries Optoelectronics Technology Co., China). Samples
(0.2 mg/mL in water) were irradiated under magnetic stirring
for 20 min. Temperature increase curves were registered using a
type K thermocouple (RS Components, Corby, UK) immersed
in the sample parallel to the path of the laser beam.42 As shown
in Figure 3a, irradiation of the preparations of Pd-NP B and C
resulted in a higher temperature increase than that of Pd-NP A.
These results correlate well with the superior absorbance of Pd-
NP B and C at 800 nm (see Figure S8), which suggest that the
use of histidine in the preparation of Pd-NP B and C increases
NIR light absorption and, in turn, promotes their photothermal
capabilities. The photothermal stability of Pd-NP B was
confirmed by performing six successive irradiation cycles (see
Figure S9).
As expected, analysis of changes in the temperature of the
preparations under LED (noncoherent divergent beam)
irradiation at 480 and 532 nm showed no or minimal effect
at 0.53 W/cm2 (see Figure S9), indicating that the devices
should not inflict any damage to labeled cells under normal
brightfield and fluorescence light during microscopy studies.
Laser Microscopy-Patterned PTA of Pd-Labeled
Cancer Cell Culture. The induction of PTA of cancer cells
tagged with plasmonic materials is typically performed in vitro
by irradiating an external laser source onto a plate or coverslip
containing the cells, resulting in a uniform laser exposure
throughout the cell monolayer. Our goal, however, was to
exploit the spatial accuracy and automated capabilities of laser
scanning microscopes to illuminate specific areas of a cell
monolayer with a focused NIR laser source. Irradiation of the
specimen in an automated programmable manner would enable
highly precise patterning of multiple samples with very high
reproducibility. This was achieved following the methodology
described in Figure 3b. Briefly, nonlabeled and Pd-NP B-
labeled A549 cells were stained with Calcein AM immediately
prior to irradiation. Calcein AM is a cell-penetrant pro-dye that
becomes fluorescent (Ex/Em = 495/515 nm) after entering
living cells. Designated areas of the cell culture plate were then
exposed to irradiation from a picosecond pulsed 816.8 nm NIR
laser using a 25× water immersion objective of a laser scanning
microscope Olympus FV1000MPE. Areas of irradiation were
scanned sequentially using a Prior H117 automated stage (9 ×
9 square) with an exposure time of 20 s per position. The laser
power measured after the objective was 30 mW. After
irradiation, the specimens were imaged by standard fluorescent
microscopy. As shown in Figure 3c, while both nonlabeled and
Pd-labeled cells were irradiated with the same laser on the same
area, only the specific area of Pd-NP B-labeled cells that was
Figure 3. Analysis and applications of the plasmonic properties of Pd-NP A, B, and C. (a) Measurements of the variation of the temperature under
laser irradiation (4 W/cm2) for 20 min. (b) Protocol followed for the induction of PTA at precise areas of A549 cancer cell culture using laser
scanning microscopy. (c) Fluorescent images (Ex/Em = 495/515 nm) of calcein AM-stained cancer cells after NIR laser irradiation: left panel,
nonlabeled cells; right panel, cells labeled with Pd-NP B. Only areas within the yellow lines were irradiated using a laser scanning microscope.
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exposed to the laser displayed decreased fluorescence and
damaged cells showing a complete loss of cell integrity, i.e.,
highly precise ablation of a predesignated area within the cell
monolayer.
Laser Microscopy-Patterned Wound Healing Assay.
Cell migration assays are essential to study physiological and
pathological processes.43−46 Among the number of assays
available,45 the in vitro scratch assay or wound healing assay47 is
probably the most widely used due to its reduced cost and
simplicity. Traditional protocols generating scratch-wounds
manually using pipette tips or a “rubber policeman” device are
labor intensive and limited by significant issues with reliability
and poor accuracy in the creation of equivalent scratches in
width, and the resulting edges are typically irregular. While
recent technologies (e.g., WoundMaker tool or the Oris cell
migration assay) improve throughput and reproducibility, they
are limited by the requirement for expensive device and
monitoring equipment and also by the fixed position and width
of a single wound. It would benefit the biomedical field
enormously to have a simple method that could be accessible to
most laboratories to perform customized cell migration studies
with high accuracy and reliability across multiple cell culture
devices and microtiter plate formats.
Encouraged by the simplicity of mapping out specific areas
with scanning microscopy and the precise patterning achieved
with the combination of Pd-NP B-tagged cells and laser
microscopy-guided ablation, we decided to explore the
potential of this method to establish customized cell migration
assays with high accuracy. To this end, we used squamous cell
carcinoma SSC-GFP cells, which constitutively express the
green fluorescent protein (GFP) and therefore can be easily
tracked using fluorescence microscopy.48 This labeling strategy
is further useful because, contrary to most chemical probes,
proteins such as GFP denaturalize at high temperature and
therefore the fluorescence would be conveniently switched off
upon cell ablation.
Cells were first labeled with Pd-NP B using the procedure
described before, followed by seeding in a 6-well glass bottom
plate and incubation for 24 h. Areas of irradiation were scanned
sequentially using an Olympus FV1000MPE (816.8 nm laser
and 25× immersion objective lens) with a Prior H117
automated stage (9 × 1 line) with an exposure time of 10 s
per position, resulting in a vertical line with the width of 500
μm. After patterning, the plate was introduced in an IncuCyte
ZOOM device and images (fluorescent channel) were recorded
every 2 h. As shown in Figure 4, a highly precise vertical line of
ablated cells was observable from the samples that contained
Pd-NP B-labeled cells at t = 0 (right panel), while no reduced
cell viability was observed from the nonlabeled control (left
panel). Time-lapse imaging enabled visual tracking and facile
quantification of cells migrating into the wound with optimal
accuracy and reliability.
Real-Time Cell Death and Imaging Using Coherent
Raman Microscopy. Coherent anti-Stokes Raman scattering
(CARS) microscopy is a type of fast-acquisition Raman
microscopy49 that uses the Raman active vibrational frequency
of native chemical bonds present in biomolecules to produce
image contrast. By coalignment of two incident laser beams at a
particular frequency difference, CARS can be used, for example,
to image lipids within tumors or to distinguish between normal
and malignant cells without requiring cell components staining
or expression of fluorescent-tagged proteins,48 an effective
solution for the label-free imaging of living cells and organisms
with high spatial and temporal resolution.
Since the vibrational stimulation of aliphatic CH2 groups is
achieved with NIR lasers,48 we envisaged that CARS
microscopy could be used to kill and simultaneously image
cancer cells labeled with plasmonic materials. To moderate the
intensity of the photothermal effect and thereby facilitate the
real-time visualization of the death of individual cells, A549
cancer cells were incubated with 0.02 mg/mL of Pd-NP B (10-
fold lower concentration than that used in previous assays)
following the protocol described above. Real-time movies were
recorded by probing the CH2 vibrational resonance with the
lasers tuned to 816.8 and 1064.4 nm (30 and 20 mW,
respectively) using a 25× water immersion objective of an
Olympus FV1000MPE.
As observed at the center of the movie snapshots of Figure 5,
the death of two cancer cells was clearly imaged. The cell
pointed out with a yellow arrow appeared to die by necrosis, as
indicated by its “bubbling” membrane in the mid panel (image
at 237 s). This effect can be interpreted as membrane blebbing,
which may be observed in both apoptotic cell death and
necrosis. However, the high speed of the process (see Movie
S1) suggests rapid necrotic cell injury. In contrast, the cell
designated with a white arrow became progressively rounded
without losing the integrity of the cell membrane, potentially
suggesting programmed cell death. Such distinct effects are
probably due to the induction of different degrees of
intracellular hyperthermia, suggesting that the mode of death
under a certain laser irradiation power would be dependent on
the intracellular concentration of NPs within each particular
cell. This is an important observation since the induction of
apoptosis by photothermal therapy is believed to be advanta-
geous for the treatment of cancer.50 To the best of our
knowledge, this is the first experiment showing that CARS
microscopy can be used to image and kill cancer cells labeled
Figure 4. Laser microscopy-patterned wound healing assay with SCC-
GFP cells at 0, 12, and 24 h after irradiation. Time-lapse imaging was
performed using the green fluorescent channel of an IncuCyte ZOOM
device.
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with plasmonic nanomaterials, a methodology that will be
valuable for researchers working in the field of photothermal
therapy.
In Vivo Xenograft Tissue Ablation Using Intravital
Microscopy. The skin of the mouse is a physical barrier that
impedes the direct visualization of subcutaneous tumor
xenografts by confocal or multiphoton microscopy. To enable
the study of the tumor microenvironment in vivo, researchers
have developed optical window technologies that replace the
mouse skin by a sterile glass coverslip.51 These complex
engineered devices facilitate high-resolution imaging of tumors
in vivo at tissue, cellular, and subcellular levels to monitor
tumor development or response to therapeutic treatments.52
The recent introduction of CARS microscopy for intravital
windows technology has expanded our capacity to visualize the
tumor microenvironment without the need of fluorophores.48
On the basis of the high biocompatibility, labeling capacity, and
photothermal properties of Pd-NP B, we envisaged that we
could generate Pd-labeled tumor xenografts that could be
grown and, in turn, ablated in vivo using intravital CARS
microscopy.
Dorsal window chambers were implanted into CD-1 nude
mice as previously described.53 A549 cells were labeled with
Pd-NP B (0.2 mg/mL) following the procedure described
above and implanted into the center of the window, and a glass
coverslip was held in place using a circlip to seal the window.
Xenografts of unlabeled cancer cells were used as negative
control. Tumors were allowed to grow under the windows and
then imaged under NIR irradiation by CARS microscopy at
different areas on and outside of the tumor. Imaging/irradiation
of the Pd-NP-labeled tumor tissue clearly revealed areas devoid
of cells (Figure 6b, right panel) while, in contrast, the healthy
(unlabeled) tissue of the same animal showed an intact
physiology (Figure 6b, left panel). As previously reported,48
intravital CARS imaging of a tumor xenograft composed of
cancer cells without Pd-NP B showed no signs of cell ablation
(see Figure S12). This proof-of-concept study demonstrates
that the combination of CARS microscopy, intravital window
technology, and biocompatible plasmonic nanomaterials can be
applied to induce photothermal tissue ablation in designated
areas of a tumor xenograft. While this method cannot be
directly compared with standard PTA techniques (which
typically employ optical fibers to irradiate large areas of
xenografted malignancies), it could be used to induce and study
in vivo microinjuries and, potentially, find application in
precision medicine to treat superficial metastatic microlesions
in combination with an appropriate tumor homing strategy
(e.g., exploiting the enhanced permeability and retention (EPR)
effect or incorporating cancer-targeting peptides on the surface
of the NPs).
■ CONCLUSIONS
Highly biocompatible plasmonic Pd-NPs of around 6 nm in
average diameter have been generated using a green, easily
scalable synthetic procedure of high simplicity and reproduci-
bility. Analysis of intracellular Pd content and TEM images
demonstrated the capacity of one of the preparations (Pd-NP
Figure 5. Snapshots of a real-time movie of Pd-NP B-labeled cancer
cells under CARS stimulation. The yellow arrow indicates a cell dying
by necrosis, and the white arrow points to a cell progressively changing
its morphology into a rounded shape.
Figure 6. (a) In vivo xenograft tissue ablation using intravital CARS microscopy. Cancer cells were labeled with Pd-NP B before implantation. (b)
Combined false color in vivo image of xenograft tissue. Images were generated using a CARS stimulation and filtered: nuclei (CH3) in gray,
cytoplasm (CH2) in green, and collagen fibers (second harmonic generation) in cyan. Images were taken at the healthy tissue outside the A549
tumor (left panel) and at the center of the tumor (right panel). Ablated tissue areas are identified by dark openings of various sizes and shapes. Scale
bars = 25 μm.
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B) to enter cancer cells and stay harmlessly in the cytoplasm.
Notably, such NPs display high photothermal activity upon
exposure to NIR laser irradiation. By labeling cancer cells with
Pd-NP B, designated areas of cell culture specimens were
precisely irradiated and ablated using a laser scanning
microscope. Using this novel methodology, we developed an
innovative wound healing assay that can be readily, and cost
effectively, customized across multiple cell types and culture
formats to facilitate more robust cell migration studies toward
new applications and increased disease relevance. Finally, on
the basis of the safety and optical properties of Pd-NP B, PTA
studies were performed in combination with CARS microscopy
both in vitro and in vivo, demonstrating the capacity of this
method to “image & ignite” cell ablation in real time with high
spatial precision. The concept of using CARS microscopy both
to mediate and to monitor cell death in real time with robotic
accuracy could open up new avenues to diversify the
applicability of plasmonic materials in biomedical research
and accelerate their clinical translation toward novel precision
medicine initiatives against cancer.
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